Literature DB >> 20652290

Expression of MMP-1 in invasive well-differentiated thyroid carcinoma.

Aviram Mizrachi1, Rumelia Koren, Tuvia Hadar, Eitan Yaniv, Sara Morgenstern, Jacob Shvero.   

Abstract

The objective of this study is to examine the expression of matrix metalloproteinase 1 (MMP-1) in invasive well-differentiated thyroid carcinoma (WDTC) and its relation to clinicopathological features. This retrospective case study group included 26 patients with invasive WDTC who were treated at our center between January 1985 and May 2007. Clinical data were collected from the medical files. MMP-1 expression was tested in samples from paraffin-embedded tumor by immunohistochemical staining. MMP-1 expression correlated with laryngotracheal invasion (p = 0.032), multifocality of the tumor (p = 0.044), and presence of regional (p = 0.034) and distant metastases (p = 0.048). In conclusion, the expression of MMP-1 in invasive WDTC is consistent with tumor aggressiveness, manifested by laryngotracheal invasion, multifocality, and regional and distant metastases. MMP-1 expression may serve as a prognostic marker and an indicator for the need for more aggressive surgical treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652290     DOI: 10.1007/s00405-010-1343-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  24 in total

Review 1.  Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; R T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

2.  Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.

Authors:  P O-Charoenrat; P H Rhys-Evans; S A Eccles
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-07

3.  Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression.

Authors:  W-C Chiang; Y-K Wong; S-C Lin; K-W Chang; C-J Liu
Journal:  Oral Dis       Date:  2006-01       Impact factor: 3.511

4.  Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.

Authors:  K Cho Mar; T Eimoto; H Tateyama; Y Arai; Y Fujiyoshi; M Hamaguchi
Journal:  Histopathology       Date:  2006-02       Impact factor: 5.087

Review 5.  Matrix metalloproteinases (MMPs) in health and disease: an overview.

Authors:  Charles J Malemud
Journal:  Front Biosci       Date:  2006-05-01

Review 6.  Matrix metalloproteinases and the thyroid.

Authors:  Z Kraiem; S Korem
Journal:  Thyroid       Date:  2000-12       Impact factor: 6.568

7.  Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.

Authors:  E Baldini; M Toller; F M Graziano; F P Russo; M Pepe; L Biordi; E Marchioni; F Curcio; S Ulisse; F S Ambesi-Impiombato; M D'Armiento
Journal:  Thyroid       Date:  2004-11       Impact factor: 6.568

8.  Prognostic factors in well-differentiated thyroid carcinoma.

Authors:  Sharon L Cushing; Carsten E Palme; Nathalie Audet; Spiro Eski; Paul G Walfish; Jeremy L Freeman
Journal:  Laryngoscope       Date:  2004-12       Impact factor: 3.325

9.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

10.  Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.

Authors:  Ashok R Shaha
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

View more
  3 in total

Review 1.  Biochemical and Biological Attributes of Matrix Metalloproteinases.

Authors:  Ning Cui; Min Hu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-22       Impact factor: 3.622

2.  Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

Authors:  Ji Wang; Chenyang Ye; Demin Lu; Yongxia Chen; Yunlu Jia; Xiaogang Ying; Hanchu Xiong; Wenhe Zhao; Jichun Zhou; Linbo Wang
Journal:  Oncotarget       Date:  2017-08-24

3.  Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.

Authors:  Kotaro Ito; Yoshihiko Kitajima; Keita Kai; Shohei Matsufuji; Kohei Yamada; Noriyuki Egawa; Hiroshi Kitagawa; Keiichiro Okuyama; Tomokazu Tanaka; Hirokazu Noshiro
Journal:  Int J Oncol       Date:  2021-11-05       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.